Skip to main content
. Author manuscript; available in PMC: 2008 Sep 1.
Published in final edited form as: Neuropharmacology. 2007 Jun 28;53(3):447–454. doi: 10.1016/j.neuropharm.2007.06.009

Table 1.

Baseline neuropeptide levels (ng/mg) in 11 regions of control human brain samples (Mean ± SEM)

Brain Region Dynorphin (DYN) Metenkephalin (MENK) Neuropeptide Y (NPY) Neurotensin (NT) Substance P (SP)
Caudate Nucleus 0.42 ±.06 7.42 ± 1.14 4.83 ± 0.41 0.12 ± .01 3.41 ± 0.31
Nucleus Accumbens 7.81 ± 1.13 12.83 ± 2.01 35.63 ± 2.52 1.16 ± 0.11 6.02 ± 0.42
Cortex 9 0.11 ± 0.01 1.54 ± 0.08 21.02 ± 3.30 0.07 ± 0.01 0.30 ± 0.02
Cortex 18 0.08 ± 0.01 1.02 ± 0.10 26.90 ± 1.67 0.08 ± 0.01 0.40 ± 0.03
Cortex 22 (Auditory Associative Cortex) 0.08 ± 0.01 12.14 ± 0.13 8.90 ± 0.55 0.033 ± 0.002 0.28 ± 0.02
Cortex 39 (Visual Cortex) 0.042 ± 0.003 7.12 ± 0.42 11.77 ± 0.78 0.081 ± 0.012 0.32 ±0.025
Nucleus Basalis 1.27 ± 0.21 4.70 ± 0.61 15.56 ± 2.33 1.28 ± 0.26 3.30 ± 0.34
Nucelus Lateralis (Thalamus) 0.027 ± 0.002 1.17 ± 0.11 0.97 ± 0.068 0.101 ± 0.011 0.148 ± 0.03
Medial Pulvinar Thalamus 0.035 ± 0.004 0.355 ± 0.050 1.20 ± 0.15 0.224 ± 0.038 0.962 ± 0.200
Putamen 0.363 ± 0.067 16.48 ± 2.78 12.43± 1.71 0.165 ± 0.029 2.84 ± 0.39
Substantia Innominata (Extended Amygdala) 2.45 ± 0.77 6.46 ± 0.57 17.61 ± 2.06 0.78 ± 0.16 3.96 ± 0.53